Skip to main navigation Skip to search Skip to main content

A 30-UTR KRAS-variant is associated with cisplatin resistance in patients with recurrent and/or metastatic head and neck squamous cell carcinoma

  • Christine H. Chung
  • , J. W. Lee
  • , R. J. Slebos
  • , J. D. Howard
  • , J. Perez
  • , H. Kang
  • , E. J. Fertig
  • , M. Considine
  • , J. Gilbert
  • , B. A. Murphy
  • , S. Nallur
  • , T. Paranjape
  • , R. C. Jordan
  • , J. Garcia
  • , B. Burtness
  • , A. A. Forastiere
  • , J. B. Weidhaas

Research output: Contribution to journal › Article › peer-review

25   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'A 30-UTR KRAS-variant is associated with cisplatin resistance in patients with recurrent and/or metastatic head and neck squamous cell carcinoma'. Together they form a unique fingerprint.
Sort by

Keyphrases

Immunology and Microbiology

Biochemistry, Genetics and Molecular Biology